Artículos por temáticas

Does feature selection improve classification accuracy? Impact of sample size and feature selection on classification using anatomical magnetic resonance images

Chu C, Hsu AL, Chou KH, Bandettini P, Lin C; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2012 Mar;60(1):59-70. doi: 10.1016/j.neuroimage.2011.11.066. Epub 2011 Dec 1.

Linking atherosclerosis to Alzheimer's disease: focus on biomarkers

Emanuele E, Martinelli V, Abbiati V, Ricevuti G.

Front Biosci (Elite Ed). 2012 Jan 1;4(2):700-10. doi: 10.2741/411.

Attention-related networks in Alzheimer's disease: a resting functional MRI study

Li R, Wu X, Fleisher AS, Reiman EM, Chen K, Yao L.

Hum Brain Mapp. 2012 May;33(5):1076-88. doi: 10.1002/hbm.21269. Epub 2011 Apr 29.

White matter integrity and vulnerability to Alzheimer's disease: preliminary findings and future directions

Gold BT, Johnson NF, Powell DK, Smith CD.

Biochim Biophys Acta. 2012 Mar;1822(3):416-22. doi: 10.1016/j.bbadis.2011.07.009. Epub 2011 Jul 23.

Takotsubo cardiomyopathy in an elderly patient with severe Alzheimer's disease: a case report

Cerri AP, Teruzzi F, Gregorio M, Bellelli G, Annoni G.

J Am Med Dir Assoc. 2012 Mar;13(3):207-9. doi: 10.1016/j.jamda.2011.09.002. Epub 2011 Oct 12.

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach

Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT; National Institu

Acta Neuropathol. 2012 Jan;123(1):1-11. doi: 10.1007/s00401-011-0910-3. Epub 2011 Nov 20.

Genome-wide association study of Alzheimer's disease with psychotic symptoms

Hollingworth P, Sweet R, Sims R, Harold D, Russo G, Abraham R, Stretton A, Jones N, Gerrish A, Chapman J, Ivanov D, Moskvina V, Lovestone S, Priotsi P, Lupton M, Brayne C, Gill M, Lawlor B, Lynch A, C

Mol Psychiatry. 2012 Dec;17(12):1316-27. doi: 10.1038/mp.2011.125. Epub 2011 Oct 18.

Soluble Aβ oligomer production and toxicity

Larson ME, Lesné SE.

J Neurochem. 2012 Jan;120 Suppl 1(Suppl 1):125-139. doi: 10.1111/j.1471-4159.2011.07478.x. Epub 2011 Nov 28.

Tau-targeted treatment strategies in Alzheimer's disease

Götz J, Ittner A, Ittner LM.

Br J Pharmacol. 2012 Mar;165(5):1246-59. doi: 10.1111/j.1476-5381.2011.01713.x.

Brain imaging in the study of Alzheimer's disease

Reiman EM, Jagust WJ.

Neuroimage. 2012 Jun;61(2):505-16. doi: 10.1016/j.neuroimage.2011.11.075. Epub 2011 Dec 7.

The contributions of unscheduled neuronal cell cycle events to the death of neurons in Alzheimer's disease

Herrup K.

Front Biosci (Elite Ed). 2012 Jan 1;4(6):2101-9. doi: 10.2741/527.

Diagnostic power of default mode network resting state fMRI in the detection of Alzheimer's disease

Koch W, Teipel S, Mueller S, Benninghoff J, Wagner M, Bokde AL, Hampel H, Coates U, Reiser M, Meindl T.

Neurobiol Aging. 2012 Mar;33(3):466-78. doi: 10.1016/j.neurobiolaging.2010.04.013. Epub 2010 Jun 11.

Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease

Lehmann M, Koedam EL, Barnes J, Bartlett JW, Ryan NS, Pijnenburg YA, Barkhof F, Wattjes MP, Scheltens P, Fox NC.

Neurobiol Aging. 2012 Mar;33(3):627.e1-627.e12. doi: 10.1016/j.neurobiolaging.2011.04.003. Epub 2011 May 18.

Unbiased comparison of sample size estimates from longitudinal structural measures in ADNI

Holland D, McEvoy LK, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2012 Nov;33(11):2586-602. doi: 10.1002/hbm.21386. Epub 2011 Aug 9.

Complement activation as a biomarker for Alzheimer's disease

Aiyaz M, Lupton MK, Proitsi P, Powell JF, Lovestone S.

Immunobiology. 2012 Feb;217(2):204-15. doi: 10.1016/j.imbio.2011.07.023. Epub 2011 Jul 23.